Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks at record high but yields fall, dollar under pressure

Fri, 27th Nov 2020 20:02

* Highly anticipated vaccine facing more scrutiny

* Treasury yields fall, point to lingering COVID-19 worries

* Bitcoin extends Thursday's big losses

* USD index closes at 2-1/2 year low

* U.S. markets on shortened hours after Thanksgiving holiday

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh
(Updates to U.S. market close)

By Rodrigo Campos

NEW YORK, Nov 27 (Reuters) - Stocks rose across the globe on Friday to close
at a fresh high and remained on track for their strongest monthly performance on
record but the Nasdaq outperformed on Wall Street and Treasury yields fell,
indicating lingering concerns over rising coronavirus cases globally.

A global stock index touched a record high for the third session this week
while the dollar index, a measure of the greenback versus six peers, touched a
three-month low and closed at its lowest since April 2018.

On Wall Street, the main indexes rose and the Nasdaq Composite hit a record
high. The Nasdaq outperformance mirrors recent sessions when, despite rising
stocks, the focus was on the economic impact of the pandemic. The U.S. expects a
further surge in coronavirus infections following the Thanksgiving holiday.

The Dow Jones Industrial Average rose 37.9 points, or 0.13%, to
29,910.37, the S&P 500 gained 8.7 points, or 0.24%, to 3,638.35 and the
Nasdaq Composite added 111.44 points, or 0.92%, to 12,205.85.

European stocks rose after the European Central Bank reinforced expectations
of further stimulus next month and Sweden's Riksbank made a surprise increase to
its quantitative-easing program.

The pan-European STOXX 600 index rose 0.41% and MSCI's gauge of
stocks across the globe gained 0.39% to 623.75 after touching a
high of 624.29.

Emerging market stocks rose 0.12%, while Japan's Nikkei rose 0.40%.

Questions also lingered over trial data on AstraZeneca's COVID-19
"vaccine for the world," as several scientists sounded caution over the trial
results.

Australian shares ended down 0.5% with Treasury Wine Estates
down 11.25% as China imposed new tariffs on Australian wine, the latest
move in the countries' long-running trade row.

The European Union and Britain said substantial differences remained over a
Brexit trade deal, as the EU chief negotiator prepared to travel to London in a
last-ditch attempt to avoid a tumultuous finale to the five-year crisis.

Sterling, which has climbed over 3% against the dollar this month, was last
trading at $1.3299, down 0.42% on the day.

"Clearly, there are substantial and important differences still to be
bridged, but we're getting on with it," British Prime Minister Boris Johnson
told reporters.

The dollar index fell 0.269%, with the euro up 0.39% to
$1.196. The Japanese yen strengthened 0.24% versus the greenback at 104.03 per
dollar.

"Over the longer term, this is probably the right trend for the dollar. We
think the dollar has further room to the downside," said Bipan Rai, North
America head of foreign exchange strategy at CIBC Capital Markets.

The yield on benchmark Treasury notes fell as some investors
sought the safety of holding government debt over persistent concerns about the
surge in coronavirus cases and lockdowns in several U.S. states and around the
world.

The 10-year notes last rose 11/32 in price to yield 0.8422%, from 0.878%
late on Wednesday.

Oil prices, up for a fourth straight week, were mixed.

U.S. crude recently fell 0.42% to $45.52 per barrel and Brent
was at $48.27, up 0.98% on the day. Both rose over 7% this week.

Bitcoin fell 2.25% to $16,774.49 after tumbling 8.4% in the
previous session. The cryptocurrency brushed against its record high of $19,666
earlier this week and has rallied around 130% this year.

Spot gold dropped 1.3% to $1,787.40 an ounce. Silver fell
3.20% to $22.70.

(Reporting by Rodrigo Campos; additional reporting by Sinéad Carew in New York,
Marc Jones in London and Shivani Kumaresan in Bengaluru
Editing by Nick Zieminski
)

More News
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more
1 Feb 2024 15:52

UK earnings, trading statements calendar - next 7 days

Friday 2 February 
YouGov PLCTrading Statement
Monday 5 February 
Home REIT PLCTrading Statement
Porvair PLCFull Year Results
Trident Royalties PLCTrading Statement
Vodafone Group PLCTrading Statement
Tuesday 6 February 
Alumasc Group PLCHalf Year Results
BP PLCFull Year Results
Filtronic PLCHalf Year Results
Mattioli Woods PLCHalf Year Results
Renishaw PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Wednesday 7 February 
Ashmore Group PLCHalf Year Results
Barratt Developments PLCHalf Year Results
HydrogenOne Capital Growth PLCTrading Statement
Phoenix Spree Deutschland LtdTrading Statement
PZ Cussons PLCHalf Year Results
Smurfit Kappa Group PLCFull Year Results
UK Commercial Property REIT LtdTrading Statement
Thursday 8 February 
Anglo American PLCTrading Statement
AstraZeneca PLCFull Year Results
British American Tobacco PLCFull Year Results
Compass Group PLCTrading Statement
Redrow PLCHalf Year Results
SSE PLCTrading Statement
Unilever PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
29 Jan 2024 08:19

TOP NEWS: AstraZeneca, Daiichi's Enhertu granted priority review in US

(Alliance News) - AstraZeneca PLC on Monday said its cancer drug conjugate received priority review by the Food & Drug Administration in the US for patients with metastatic HER2-positive solid tumours.

Read more
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.